Clinical Trials Logo

Clinical Trial Summary

The study confirms the performance equivalence of the in vitro Diagnostic reagent ABTEST card used with the new reformulated WS solution


Clinical Trial Description

The study consists to perform on 100 patients a first pre transfusional control with the reference in vitro reagent ABTEST card (CE Marked reagent) followed by a another pre transfusional control with the in vitro reagent ABTEST card in study (new reformulated WS solution used) . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05140395
Study type Interventional
Source Diagast
Contact
Status Completed
Phase N/A
Start date June 6, 2021
Completion date November 4, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT03885570 - Blood Transfusion Management in Patients With Mitral Valve Replacement in China
Recruiting NCT06403163 - Transfusion Surveillance in Anaesthesia
Withdrawn NCT03056378 - POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units Phase 1
Completed NCT02423135 - Detection of Autologous DEHP (DiEthylHexyl Phthalate)-Free Blood Transfusion in Anti-doping N/A
Completed NCT02200692 - Allergic Transfusion Reactions in Plasma Transfusion
Completed NCT02841111 - Old Red Blood Cell In Renal Transplantation N/A
Completed NCT04267029 - Transfusion Associated Dyspnea Profiling
Completed NCT02607150 - Changes in Cerebral Oxygenation During the Administration of Cell Saver Blood and Allogeneic Blood N/A
Recruiting NCT03855644 - Blood Transfusion Among Patients With Pelvic Fracture in China
Active, not recruiting NCT03182491 - Mechanisms of Anaphylaxis